« Back to Record
Porter, M. M., Martorell, A., Sayed, C. C., Bechara, F. G., Lev-Tov, H., Hsiao, J. L., Frew, J. J., Reguiai, Z., Gooderham, M., Goldfarb, N., Van der Zee, H. H., Del Marmol, V., Marzano, A. V., Ehst, B. B., Ackerman, L. L., Hayama, K., Tian, C., Kelley, J., Zhen, H., Kirby, J. S., Brown, K., Santos, L. L., & Zouboulis, C. C. (2026). Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials. Nature medicine, 32(8), 3071-3081. doi:10.1038/s41591-026-04534-z
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/415880



